The healthcare packaging market is predicted to see good growth, especially in emerging markets, but new demands by health and regulatory authorities and moves towards personalised medicines mean design changes.
The global healthcare packaging market will reach a value of US$96.2bn in 2013, according to market analysis by Visiongain.1 In the Asia-Pacific region, increased drug production and infrastructure development will dominate that growth, while a thriving middle class is likely to create a strong demand for healthcare packaging in developing countries. In the more mature markets, such as the US and Western Europe, an increasing ageing population will drive the growth of healthcare packaging.
In Visiongain’s report, Global Healthcare Packaging Market 2013-2023, healthcare packaging is forecast to see a steady growth with constant demand and, as emerging economies grow, demand for healthcare packaging will increase, further strengthening the market.
In its last packaging report, Packaging Unwrapped (2011),2 global packaging producer Rexam said Western Europe, the US and Japan account for more than 70% of the total market. It estimated that the Asia Pacific region represented just under a quarter of all global pharmaceutical packaging in terms of value. Central and South America, Eastern Europe and the Middle East and Africa region combined make up just 10% of the global pharmaceutical packaging market with most of the demand being standard containers and closures for low cost generic drugs.
However, it added that in the longer term, developing regions, especially China, India, Brazil and South Korea, offer the fastest growth opportunities for pharmaceutical packaging. This will be driven by the expansion and diversification of pharmaceutical manufacturing capabilities in these regions as well as efforts to improve the quality and integrity of medicines.